183 related articles for article (PubMed ID: 3734843)
1. Intralymphatic autochthonous tumor cell vaccine in canine lymphoma.
Jeglum KA; Young KM; Barnsley K; Whereat A; McGrath D; Hutson C
J Biol Response Mod; 1986 Apr; 5(2):168-75. PubMed ID: 3734843
[TBL] [Abstract][Full Text] [Related]
2. In vitro immune monitoring of antibody response in dogs given chemoimmunotherapy for lymphoma.
Jeglum KA; Winters WD; Young KM
Am J Vet Res; 1989 Apr; 50(4):488-92. PubMed ID: 2712415
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy versus chemotherapy with intralymphatic tumor cell vaccine in canine lymphoma.
Jeglum KA; Young KM; Barnsley K; Whereat A
Cancer; 1988 May; 61(10):2042-50. PubMed ID: 3359402
[TBL] [Abstract][Full Text] [Related]
4. Chemoimmunotherapy for canine lymphosarcoma: a prospective evaluation of specific and nonspecific immunomodulation.
Weller RE; Theilen GH; Madewell BR; Crow SE; Benjamini E; Villalobos A
Am J Vet Res; 1980 Apr; 41(4):516-21. PubMed ID: 6893260
[TBL] [Abstract][Full Text] [Related]
5. Autologous marrow transplantation as consolidation therapy for canine lymphoma: efficacy and toxicity of various regimens of total body irradiation.
Deeg HJ; Appelbaum FR; Weiden PL; Hackman RC; Graham TC; Storb RC
Am J Vet Res; 1985 Sep; 46(9):2016-8. PubMed ID: 3901841
[TBL] [Abstract][Full Text] [Related]
6. Histologic classification as an indication of therapeutic response in malignant lymphoma of dogs.
Gray KN; Raulston GL; Gleiser CA; Jardine JH
J Am Vet Med Assoc; 1984 Apr; 184(7):814-7. PubMed ID: 6725115
[TBL] [Abstract][Full Text] [Related]
7. Chemoimmunotherapy for canine lymphosarcoma.
Theilen GH; Worley M; Benjamini E
J Am Vet Med Assoc; 1977 Mar; 170(6):607-10. PubMed ID: 576595
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of asparaginase administered subcutaneously versus intramuscularly for treatment of multicentric lymphoma in dogs receiving doxorubicin.
Valerius KD; Ogilvie GK; Fettman MJ; Walton JA; Richardson K; Powers BE; McNiel EA; Rogers QR
J Am Vet Med Assoc; 1999 Feb; 214(3):353-6. PubMed ID: 10023395
[TBL] [Abstract][Full Text] [Related]
9. Principles of treatment for canine lymphoma.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):92-7. PubMed ID: 12831068
[TBL] [Abstract][Full Text] [Related]
10. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma.
MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD
J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843
[TBL] [Abstract][Full Text] [Related]
11. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study.
Longo DL; Duffey PL; Gribben JG; Jaffe ES; Curti BD; Gause BL; Janik JE; Braman VM; Esseltine D; Wilson WH; Kaufman D; Wittes RE; Nadler LM; Urba WJ
Cancer J; 2000; 6(3):146-50. PubMed ID: 10882329
[TBL] [Abstract][Full Text] [Related]
13. Regional intralymphatic infusion (ILI) of irradiated tumor cells with evidence of distant effects.
Juillard GJ; Boyer PJ; Yamashiro CH; Snow HD; Weisenburger TH; McCarthy T; Miller RJ
Cancer; 1977 Jan; 39(1):126-30. PubMed ID: 832227
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
16. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
17. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of mitoxantrone for the treatment of lymphoma in dogs.
Moore AS; Ogilvie GK; Ruslander D; Rand WS; Cotter SM; Getzy DM; L'Heureux DA; Dennis RA
J Am Vet Med Assoc; 1994 Jun; 204(12):1903-5. PubMed ID: 8077132
[TBL] [Abstract][Full Text] [Related]
19. Total body irradiation and autologous marrow transplantation as consolidation therapy for spontaneous canine lymphoma in remission.
Weiden PL; Storb R; Deeg HJ; Graham TC
Exp Hematol; 1979; 7 Suppl 5():160-3. PubMed ID: 400683
[TBL] [Abstract][Full Text] [Related]
20. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
